The politically and emotionally charged issue of pharmaceutical
reimportation took center stage in Ann Arbor, Oct. 29-31, when the
College of Pharmacys Center for Medication Use, Policy, and
Economics (CMUPE) hosted the conference, Reimportation
of Pharmaceuticals: Economic and Policy Implications. The
event, which was underwritten by AstraZeneca, Aventis, and the Michigan
Pharmacists Association, brought together a variety of private
and public policy makers, each with a different viewpoint on the topic.
One goal of the Center is to encourage responsible use of
pharmaceuticals through balanced, objective debate of benefits and
risks, observes CMUPE Director Patrick
McKercher who, with Assistant Professors David
Nau and Stephanie
Taylor in the Colleges Department
of Social and Administrative Sciences, orchestrated the reimportation
conference. Drug reimportation falls into the category of
pharmaceutical issues demanding objective debate. The purpose of
the conference was to provide a forum to share policy research and
wide-ranging perspectives related to reimportation of pharmaceuticals.
We achieved that end.
Taylor notes that academic pharmacists have a special role in tackling
the tough question of whether Americans should be allowed to buy prescription
drugs from outside the U.S.
The
topic of pharmaceutical reimportation has been at the fore of Congressional
deliberations over Medicare prescription drug coverage, Taylor
says. The social, political, and economic complexity of this
issue has created a lot of misunderstanding. As academic pharmacists,
we can help clarify some issues and help create consensus by bringing
together researchers and experts from academia, policy centers,
and stakeholder organizations and agencies.
In the case of Michigan, we also have first-hand experience
to draw upon. Because of the states proximity to Canada, American
consumers frequently cross the U.S. border, here, to buy pharmaceuticals
at discount prices in Canada.
The conference attracted participants representing industry, U.S.
and Canadian government agencies, pharmacy trade organizations, key
U.S. Congressional committees, academic and non-academic researchers
engaged in the economics of intellectual property, and experts in
pharmaceutical distribution channels, policies, and practices.
Reimportation conference presentations may be viewed on the College
Web site at: http://sitemaker.umich.edu/reimportationofpharmaceuticals/agenda.
CMUPE and Managed Care Journal also will publish a supplement of
presentations made during the two-day reimportation conference.
For more information about the conference proceedings publication,
contact Pat McKercher at 734-647-8075 or pmckerch@umich.edu..
|
|